Our findings demonstrate that CXCR4 antagonism effectively corrected peripheral blood neutropenia, restored reduced splenic neutrophil counts, normalized mature neutrophil accumulation in BM, and normalized the M/E ratio and MK-like phenotype in BM of CXCR2 LOF mice. This evidence concerns the gene CXCR2 and Decreased total neutrophil count.